Metraipolis › archive › dc_4774d910bb93

Design and methods of the Ixekizumab Diabetes Intervention Trial (I-DIT): protocol for a phase 2, randomised, multicentre, placebo-controlled, double-blind… — Europe PMC PMID:41224288

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41224288
DOI
10.1136/bmjopen-2025-103486
License (as archived)
solo-consultazione
Archived
2026-11-08T15:20:04.493Z
SHA-256 of the archived text
a406e5244a61d4a314338dfca02358302ce198ab371a3fcfe101b5aecd420879
Stable URL of this page
https://metraipolis.com/documento/dc_4774d910bb93

How to cite

Design and methods of the Ixekizumab Diabetes Intervention Trial (I-DIT): protocol for a phase 2, randomised, multicentre, placebo-controlled, double-blind… — Europe PMC PMID:41224288 — Europe PMC (en), https://europepmc.org/article/MED/41224288 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4774d910bb93 (Metraipolis archive dc_4774d910bb93, sha256 a406e5244a61d4a314338dfca02358302ce198ab371a3fcfe101b5aecd420879)
BibTeX
@misc{dc4774d910bb93,
  title = {Design and methods of the Ixekizumab Diabetes Intervention Trial (I-DIT): protocol for a phase 2, randomised, multicentre, placebo-controlled, double-blind… — Europe PMC PMID:41224288},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41224288},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4774d910bb93; sha256 a406e5244a61d4a314338dfca02358302ce198ab371a3fcfe101b5aecd420879},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41224288. Agents can read the archived copy with the MCP tool read_document.